New Cream Treats Basal Cell Cancers
A prescription cream recently approved to treat select superficial basal cell carcinomas (sBCCs) may provide an alternative to skin surgery in certain cases. The FDA approved 3M’s Aldara (imiquimod) in July.
Dermatologist Craig Elmets, M.D., one of the investigators in its clinical trials, says imiquimod will be “useful for treating patients in whom surgical procedures are difficult, including elderly patients, patients with sBCCs at cosmetically sensitive areas where scarring is a concern, and patients who don’t want surgery.”
The patient applies it before sleeping, five times weekly for six weeks. “Applying cream isn’t hard for an elderly person, and is easier than caring for a post-surgical wound.” Most people will still elect simple destructive techniques, which themselves carry a very high rate of cure.
Media Contact
More Information:
http://www.uab.eduAll latest news from the category: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
Newest articles
Properties of new materials for microchips
… can now be measured well. Reseachers of Delft University of Technology demonstrated measuring performance properties of ultrathin silicon membranes. Making ever smaller and more powerful chips requires new ultrathin…
Floating solar’s potential
… to support sustainable development by addressing climate, water, and energy goals holistically. A new study published this week in Nature Energy raises the potential for floating solar photovoltaics (FPV)…
Skyrmions move at record speeds
… a step towards the computing of the future. An international research team led by scientists from the CNRS1 has discovered that the magnetic nanobubbles2 known as skyrmions can be…
